p53-Independent and -dependent requirements for E1B-55K in adenovirus type 5 replication.
about
Analysis of the adenovirus E1B-55K-anchored proteome reveals its link to ubiquitination machinery.Going viral: a review of replication-selective oncolytic adenovirusesAdvances in preclinical investigation of prostate cancer gene therapy.Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death proteinTissue-specific, tumor-selective, replication-competent adenovirus vector for cancer gene therapy.Replicating adenoviruses that target tumors with constitutive activation of the wnt signaling pathwayBiological approaches to therapy of pancreatic cancer.Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study.Targeting of p53-transcriptional dysfunction by conditionally replicating adenovirus is not limited by p53-homologues.Adenoviral vector-mediated gene therapy for gliomas: coming of age.Does the antitumor adenovirus ONYX-015/dl1520 selectively target cells defective in the p53 pathway?Adenovirus E1B 55-kilodalton protein is required for both regulation of mRNA export and efficient entry into the late phase of infection in normal human fibroblastsThe human adenovirus type 5 E1B 55 kDa protein obstructs inhibition of viral replication by type I interferon in normal human cells.Developing novel oncolytic adenoviruses through bioselectionSmall tumor antigen of polyomaviruses: role in viral life cycle and cell transformationEffects of mutations in the adenoviral E1B 55-kilodalton protein coding sequence on viral late mRNA metabolism.Inhibition of p53 by adenovirus type 12 E1B-55K deregulates cell cycle control and sensitizes tumor cells to genotoxic agentsIncreasing the efficacy of oncolytic adenovirus vectorsAdenovirus ubiquitin-protein ligase stimulates viral late mRNA nuclear export.Timely synthesis of the adenovirus type 5 E1B 55-kilodalton protein is required for efficient genome replication in normal human cells.Arg-Gly-Asp (RGD)-Modified E1A/E1B Double Mutant Adenovirus Enhances Antitumor Activity in Prostate Cancer Cells In Vitro and in MiceConditionally replicating adenoviruses for cancer treatment.Role of the RNA recognition motif of the E1B 55 kDa protein in the adenovirus type 5 infectious cycle.Adenoviral protein V promotes a process of viral assembly through nucleophosmin 1.Reduced infectivity of adenovirus type 5 particles and degradation of entering viral genomes associated with incomplete processing of the preterminal protein.The p53 protein does not facilitate adenovirus type 5 replication in normal human cells.Gene therapy for bladder cancer using E1B-55 kD-deleted adenovirus in combination with adenoviral vector encoding plasminogen kringles 1-5.Adenovirus E1B 55-kilodalton protein: multiple roles in viral infection and cell transformation.Comparison of protein expression during wild-type, and E1B-55k-deletion, adenovirus infection using quantitative time-course proteomics.The human adenovirus 5 L4 promoter is activated by cellular stress response protein p53.Analyses of single-amino-acid substitution mutants of adenovirus type 5 E1B-55K proteinAdenovirus exploits the cellular aggresome response to accelerate inactivation of the MRN complex.Oncolytic adenoviral mutants with E1B19K gene deletions enhance gemcitabine-induced apoptosis in pancreatic carcinoma cells and anti-tumor efficacy in vivo.Replication of an E1B 55-kilodalton protein-deficient adenovirus (ONYX-015) is restored by gain-of-function rather than loss-of-function p53 mutants.Adenovirus E1B55K region is required to enhance cyclin E expression for efficient viral DNA replication.E1A-expressing adenoviral E3B mutants act synergistically with chemotherapeutics in immunocompetent tumor models.Conditionally replicating adenoviruses kill tumor cells via a basic apoptotic machinery-independent mechanism that resembles necrosis-like programmed cell death.Normal human cell proteins that interact with the adenovirus type 5 E1B 55kDa protein.Effects of febrile temperature on adenoviral infection and replication: implications for viral therapy of cancer.E1B-55-kilodalton protein is not required to block p53-induced transcription during adenovirus infection.
P2860
Q24538586-23BCBF0B-E378-4A52-A424-44FB4F88519AQ26797520-3EF7A75D-19BE-4A24-872B-0983571F43B1Q33677054-BA026DA7-AA78-4D3A-AB2B-34BCFB91930EQ33807026-45D2515B-E806-46E6-86C4-BEE68AF13DABQ33838380-F5A64F27-E2D9-41BA-ACCF-393FF0B1B467Q33865835-25AFFC87-0529-418B-B9DE-3B9CB2125237Q33899938-EC581FCC-E584-4C54-BFD9-8384BD2B39D5Q33919629-724CCD10-6A77-4C49-8A3A-08F32298139FQ33931595-7AD0DFB7-A59C-4893-B941-4F51BB558849Q34022048-D6BCDBAE-AC6E-4EE6-A7C1-89DFF0E45DF1Q34253427-16865715-B2A7-4C5D-9FA9-346EC8379267Q34301861-882C4D8B-CA96-4AFE-A77F-88DD03B50F29Q34388476-6045F74A-F4A4-400E-80AE-AAF10FDC437CQ34471952-9441A0FB-A0AA-465B-AC8B-91EE4D072CB2Q34714730-B868A0BE-9ECD-44C3-9E09-6168508C3DBFQ34998360-2F936551-E0AC-4592-91F2-23E65C43F257Q35140413-D0963CD4-E3F8-46AA-932F-D1837D4C4FC4Q35261325-7CAC4BBC-70EA-4472-B3DA-3B21CBEE31C6Q35634994-15D8E139-5D11-4F79-BE4A-CF6C93EA7E56Q35826320-51A3CEFF-F417-47FB-BBA9-BBFC7462B547Q35901283-0EC36043-067A-49D2-8B72-5E5BEB6A4016Q35967313-2794687A-A6A7-4030-9261-7FAEDA2B6491Q36039006-93AF4F48-F3FD-4240-86D9-45E555E23A54Q36177185-7F4DDFF3-171A-4256-919E-202C8E991A9BQ36414237-6ACB5F60-CC44-4FAF-B868-B2EDF910B59DQ36827260-C98F6903-C013-46BF-8F79-4820F3E656E0Q37340383-51141715-34AF-4FBA-8C7C-7C77A824FA3FQ37391112-CEA8B23E-270E-42C7-9328-0041CF2BE5B8Q38699687-371E4576-C9A2-4E4D-B7C7-91921FAC99E0Q39106880-BF9A5AF4-CE10-4DCF-A518-027255E75B27Q39602482-F680F09E-A649-477B-BDC3-AF855D2F950BQ39612520-C6F8D6B2-7AB2-4EF6-AAFE-A7E4315E1E28Q39882822-0AF54844-4D3D-42B4-90CD-D72ED948F485Q40011883-67388253-2D31-4F6C-8616-22D9D4F6D5C1Q40018751-D5033819-CE05-4E61-A481-A5D17DEDD6D3Q40045957-CD067426-AB53-4D3B-8D6B-FF7D48C46D25Q40277603-D58CAF21-7D41-4D76-977B-7C124D13FE4FQ40353337-428700DA-BD63-4A4D-AD08-7A9FA6670552Q40481068-95987446-81A8-404F-ACA4-4F31ABD2503BQ40541104-3F615681-2F9E-4361-AF99-ADA96898786A
P2860
p53-Independent and -dependent requirements for E1B-55K in adenovirus type 5 replication.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
p53-Independent and -dependent requirements for E1B-55K in adenovirus type 5 replication.
@ast
p53-Independent and -dependent requirements for E1B-55K in adenovirus type 5 replication.
@en
type
label
p53-Independent and -dependent requirements for E1B-55K in adenovirus type 5 replication.
@ast
p53-Independent and -dependent requirements for E1B-55K in adenovirus type 5 replication.
@en
prefLabel
p53-Independent and -dependent requirements for E1B-55K in adenovirus type 5 replication.
@ast
p53-Independent and -dependent requirements for E1B-55K in adenovirus type 5 replication.
@en
P2860
P1433
P1476
p53-Independent and -dependent requirements for E1B-55K in adenovirus type 5 replication.
@en
P2093
P2860
P304
P577
1999-07-01T00:00:00Z